Skip directly to content

Minimize RSR Award Detail

Research Spending & Results

Award Detail

Awardee:NVIEW MEDICAL INC.
Doing Business As Name:nView medical Inc.
PD/PI:
  • Cristian Atria
  • (978) 712-8742
  • cristian.atria@nviewmed.com
Award Date:12/21/2020
Estimated Total Award Amount: $ 256,000
Funds Obligated to Date: $ 256,000
  • FY 2021=$256,000
Start Date:01/01/2021
End Date:09/30/2021
Transaction Type:Grant
Agency:NSF
Awarding Agency Code:4900
Funding Agency Code:4900
CFDA Number:47.041
Primary Program Source:040100 NSF RESEARCH & RELATED ACTIVIT
Award Title or Description:SBIR Phase I: Artificial Intelligence (AI) Enabled 3-Dimensional (3D) Imaging for COVID-19
Federal Award ID Number:2036690
DUNS ID:963266403
Program:SBIR Phase I
Program Officer:
  • Muralidharan Nair
  • (703) 292-7059
  • mnair@nsf.gov

Awardee Location

Street:1350 S Colonial Dr
City:Salt Lake City
State:UT
ZIP:84108-2204
County:Salt Lake City
Country:US
Awardee Cong. District:02

Primary Place of Performance

Organization Name:nView medical Inc.
Street:2681 E Parleys way, ste 107
City:Salt Lake City
State:UT
ZIP:84109-1618
County:Salt Lake City
Country:US
Cong. District:02

Abstract at Time of Award

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to improve COVID-19 treatments by providing imaging information to assess the severity and progression of the disease. Chest computed tomography (CT) has been shown to be sensitive to COVID-19 via the observation of ground-glass opacities and is being used on patients with acute symptoms. Practical considerations such as high radiation to the patient and cross contamination risk from moving the patient for imaging must be taken into account in the decision to image with CT. A 3D imaging solution that is low cost, low radiation, and mobile could provide advantages and bring quality of care while integrating efficiently in the hospital workflow. Along with addressing the current crisis, the usage of this solution to address other respiratory diseases would secure strong commercial potential for this research. This Small Business Innovation Research (SBIR) Phase I project seeks to develop and validate an artificial intelligence (AI)-enabled 3D imaging reconstruction algorithm that can be used to assess the severity and progression of respiratory diseases such as COVID-19. Current chest imaging technologies can either provide adequate image quality or efficient imaging of the lungs, but not both. Two major advances could make the imaging more efficient while also providing the required image quality. Scatter modeling has been shown to be successful in improving image quality when reconstructing from few radiographs; Preliminary data shows how Machine Learning (ML) can be integrated to enhance efficient imaging to provide higher quality images. A 3D image creation algorithm that models X-ray scatter and uses ML to reconstruct 3D images from rapid radiographs will enable using 3D imaging for respiratory diseases including COVID-19. This algorithm will be validated on cadaveric models to assess if an AI-enabled imaging system that is mobile, that can be used bedside, and that is easily draped for sterile utilization is feasible. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

For specific questions or comments about this information including the NSF Project Outcomes Report, contact us.